Quantcast

Latest Cytori Therapeutics Stories

2014-03-18 23:21:46

$8.9M Raised in Last Round Enables Heart Institute to Treat Patients with Ischemic Conditions with Their Own Adult Stem Cells Beginning Summer, 2014 in the Bahamas Freeport, Bahamas (PRWEB) March 18, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease (CAD) using adult stem cell therapy, announced today it has raised $8.9 million in its Series B offering. Passion Group founder Ali Shawkat...

2014-03-12 12:29:59

DUBLIN, Mar. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/lkv8bk/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of...

2014-02-21 23:02:24

Okyanos Selects Cytori To Provide Equipment And Supplies To Treat Patients With Coronary Artery Disease Using Their Own Adult Stem Cells Freeport, The Bahamas (PRWEB) February 21, 2014 Okyanos Heart Institute, whose mission it is to bring a new standard of care and a better quality of life to patients with coronary artery disease using adult stem cell therapy, and Cytori Therapeutics have announced that they have established a ten year supply agreement for the Celution™ System family of...

2014-02-04 12:28:51

DUBLIN, Feb. 4, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/xrndzp/regenerative) has announced the addition of the "Concise Analysis of the International Regenerative Medicine Markets" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Regenerative medicine is a way of treating injured and diseased human tissue by using laboratory-grown or therapeutically-induced human tissue as a replacement. As such, astounding new...

2014-02-04 12:27:46

LONDON, Feb. 4, 2014 /PRNewswire/ -- Edison's first report on Cytori Therapeutics, Cardiac Celution, discusses the use of concentrated adipose (fat) derived regenerative cells (ADRC) from the patient, which, when injected into damaged tissues, appear to trigger their healing. Cytori sells Celution, point-of-care disposables and a bedside device to prepare ADRC in 90 minutes or less. The procedure is flexible to use, with a potentially broad range of indications and an affordable price...

2013-12-20 23:01:51

The first patient has been treated as part of The ATHENA Trial, which derives stem cells from the patient’s own adipose (fat) tissue and injects extracted cells into damaged parts of the heart. (PRWEB) December 20, 2013 Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute announced the first patient, a 59 year old Clearwater man, has been treated as part of the ATHENA clinical trial. The trial, sponsored by San Diego-based Cytori Therapeutics, derives stem...

2013-09-19 23:22:52

Reportbuyer.com just published a new market research report: Regenerative Medicines: Bone and Joint Applications. London (PRWEB) September 19, 2013 INTRODUCTION Regenerative medicine in orthopedic applications is a $2.7 billion per year niche sector in America’s $2.6 trillion per year healthcare system. However, it is a sector of immense interest in terms of technical and medical possibilities. The best analogy to the current state of regenerative therapies in the bone and joint healing...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related